Literature DB >> 17174758

Upregulation of serum and tissue vascular endothelial growth factor correlates with angiogenesis and prognosis of oral squamous cell carcinoma.

Zheng-Jun Shang1, Jin-Rong Li, Zu-Bing Li.   

Abstract

PURPOSE: To investigate both serum vascular endothelial growth factor (VEGF) concentrations and VEGF expression in patients with oral squamous cell carcinoma (OSCC), and to clarify whether upregulation of VEGF in OSCC patients is associated with increased microvessel density and various clinicopathologic features of patients with OSCC. PATIENTS AND METHODS: The study population included 31 patients with OSCC and 10 normal individuals. Concentration of serum VEGF was determined by using an ELISA kit. Immunohistochemistry was used to evaluate VEGF expression and microvessel density in OSCC.
RESULTS: Our results showed that both serum VEGF levels and VEGF positivity were closely associated with both regional lymph node status and clinical stage of patients with OSCC. Increased microvessel density in oral cancer tissues was significantly higher in VEGF-positive tumors than VEGF-negative tumors.
CONCLUSION: Our present study indicated that upregulation of VEGF in oral cancer was correlated with both tumor angiogenesis and disease severity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17174758     DOI: 10.1016/j.joms.2005.11.105

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  9 in total

Review 1.  Correlation of expression of hypoxia-related proteins with prognosis in oral squamous cell carcinoma patients.

Authors:  A W Eckert; M Kappler; J Schubert; H Taubert
Journal:  Oral Maxillofac Surg       Date:  2012-05-17

2.  VEGFA isoforms play a vital role in oral cancer progression.

Authors:  Kinjal R Patel; Bhairavi N Vajaria; Rasheedunnisa Begum; Jayendra B Patel; Franky D Shah; Geeta M Joshi; Prabhudas S Patel
Journal:  Tumour Biol       Date:  2015-03-25

3.  Upregulation of serum vascular endothelial growth factor and matrix metalloproteinase-3 in patients with oral squamous cell carcinoma.

Authors:  Azadeh Andisheh-Tadbir; Bijan Khademi; Fereshteh Kamali; Mohammad Javad Fattahi; Mahyar Malekzadeh; Masumeh Taghva
Journal:  Tumour Biol       Date:  2014-02-28

4.  Plasma vascular endothelial growth factor dysregulation in defining aggressiveness of head and neck squamous cell carcinoma.

Authors:  Boonchu Kulapaditharom; Vipa Boonkitticharoen; Chanika Sritara
Journal:  J Oncol       Date:  2011-12-15       Impact factor: 4.375

Review 5.  Vascular Endothelial Growth Factor: A Translational View in Oral Non-Communicable Diseases.

Authors:  Sven Niklander; María José Bordagaray; Alejandra Fernández; Marcela Hernández
Journal:  Biomolecules       Date:  2021-01-12

Review 6.  Intersecting Mechanisms of Hypoxia and Prostaglandin E2-Mediated Inflammation in the Comparative Biology of Oral Squamous Cell Carcinoma.

Authors:  Walaa Hamed Shaker Nasry; Chelsea K Martin
Journal:  Front Oncol       Date:  2021-05-21       Impact factor: 6.244

7.  VEGF: A critical driver for angiogenesis and subsequent tumor growth: An IHC study.

Authors:  Prakhar Kapoor; Rs Deshmukh
Journal:  J Oral Maxillofac Pathol       Date:  2012-09

8.  Upregulation of serum vascular endothelial growth factor in patients with salivary gland tumor.

Authors:  Azadeh Andisheh Tadbir; Bijan Khademi; Mahyar Malekzadeh; Maryam Mardani; Bahar Khademi
Journal:  Patholog Res Int       Date:  2013-07-24

9.  Tissue expression, serum and salivary levels of vascular endothelial growth factor in patients with HNSCC.

Authors:  Azadeh Andisheh-Tadbir; Marzieh Hamzavi; Gita Rezvani; Mohammad Javad Ashraf; Mohammad Javad Fattahi; Bijan Khademi; Fereshteh Kamali
Journal:  Braz J Otorhinolaryngol       Date:  2014-08-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.